Kolon Life Science Inc. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
139,611
130,633
121,175
158,284
118,102
Cost of Goods Sold (COGS) incl. D&A
96,447
97,710
95,661
109,999
90,115
Gross Income
43,164
32,923
25,515
48,285
27,987
SG&A Expense
24,577
23,185
23,083
29,517
33,199
EBIT
18,339
9,396
2,183
18,459
5,545
Unusual Expense
4,283
17
-
974
971
Non Operating Income/Expense
1,520
245
319
2,194
143
Interest Expense
1,752
2,107
1,443
1,407
1,028
Pretax Income
19,815
7,291
1,083
14,888
4,381
Income Tax
2,587
1,436
283
2,223
2,978
Consolidated Net Income
17,228
5,855
800
12,665
1,404
Net Income
17,228
5,855
800
12,665
1,404
Net Income After Extraordinaries
17,228
5,855
800
12,665
1,404
Net Income Available to Common
17,228
5,855
800
12,665
1,404
EPS (Basic)
2,140.08
582.01
77.52
1,176.00
185.00
Basic Shares Outstanding
8
10
10
11
8
EPS (Diluted)
2,051.79
565.12
77.34
1,175.88
184.63
Diluted Shares Outstanding
8
10
10
11
8
EBITDA
25,450
18,757
11,418
27,938
5,693
Other Operating Expense
248
342
249
310
332
Non-Operating Interest Income
466
230
23
1,003
1,363
About Kolon Life Science
View Profile
